Pharmaceutical

Novo Holdings acquires biopharma company Paratek for $462m

Novo Holdings has acquired Paratek Pharmaceuticals for nearly $462m to bolster its antimicrobial resistance (AMR) expertise.

Sep 23, 2023 - 20:00
Novo Holdings acquires biopharma company Paratek for $462m
Novo Holdings has acquired Paratek Pharmaceuticals for nearly $462m to bolster its antimicrobial resistance (AMR) expertise.
Read the original article

Tags:

Previous Article

Yale and Transcend wins US DoD grant for PTSD therapy

Next Article

Glenmark Pharma to divest 75% stake in life sciences unit for $680m

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Forge Biologics joins BGTC for new AAV gene therapies development

Forge Biologics joins BGTC for new AAV gene therapies d...

May 24, 2023

‘Shocking’ heat waves persist through August as federal officials warn of far-ranging health risks

‘Shocking’ heat waves persist through August as federal...

Aug 3, 2023

STAT+: Pharmalittle: FDA panel to review Alzheimer’s treatment; FDA advisers back approval of RSV drug for children

STAT+: Pharmalittle: FDA panel to review Alzheimer’s tr...

Jun 10, 2023